$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Comparison of the differences and advantages between domestic and imported versions of Afatinib
2026-02-01 22:25:32
Check Details
Detailed explanation of domestic pricing and medical insurance coverage of Daridorexant
2026-02-01 22:25:32
Check Details
Comparative analysis of the characteristics of olaparib (lipadro) targeted drug and chemotherapy drugs
2026-02-01 22:25:32
Check Details
Analysis of indications and clinical application population of Venetoclax/Venetoclax (Vekela)
2026-02-01 22:25:32
Check Details
Detailed instructions and medication instructions for Asnib/Assiminib (Xinbeli)
2026-02-01 22:25:32
Check Details
Analysis of the therapeutic effect of ritexitinib (Lefenox) on vitiligo and patient feedback
2026-02-01 22:25:32
Check Details
How long do side effects of Ixazomib (Enleri) usually last and how to relieve them?
2026-02-01 22:25:32
Check Details
How many tubes of rubitin/rubicatin (Zanbega) are usually needed at one time and dosage recommendations
2026-02-01 22:25:32
Check Details
Analysis of the standard dosage and usage of ensifentrine-Ohtuvayre and patient medication precautions
2026-02-01 22:25:32
Check Details
Detailed instructions on the correct method and timing of taking Roaccutane (isotretinoin) soft capsules
2026-02-01 22:25:32
Check Details
Is Doxorubicin the same as doxorubicin? Comparative analysis of similarities, differences and clinical applications between the two
2026-02-01 22:25:32
Check Details
Is Everolimus covered by medical insurance? Analysis of medical insurance policy and reimbursement process
2026-02-01 22:25:32
Check Details
1
2
...
2136
2137
2138
2139
2140
2141
2142
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
2
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
3
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
4
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
5
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
6
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
7
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
8
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
9
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
10
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
11
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
12
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment